✦ LIBER ✦

Second-line treatment with single-agent gemcitabine (GEM) in patients (PTS) with advanced non-small-cell lung cancer (NSCLC)

✍ Scribed by van Putten, J.W.G; Baas, P; Codrington, H; Kwa, H.B; Groen, H.J.M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine (GEM) as single agent in sec

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Gemcitabine (GEM) as single agent in sec

✍ Mahjoubi, R; Llory, J; Brugiere, O; Vannetzel, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Single agent gemcitabine in the second-l

✍ Ugur Coskun; Ali Osman Kaya; Süleyman Buyukberber; Mustafa Benekli; Aytug Uner; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 147 KB

First-Line Single Agent Treatment With G

✍ Yong-mei Yin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Results of the phase I-II study of gemci

✍ Faivre, S; Monnerat, C; Raymond, E; Taieb, J; Adi Vago, N; Vicente-Azevedo, J; R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Single agent Gemcitabine for elderly pat

✍ Burkes, R.L; Wilson, J; Shepherd, F.A; Spadafora, S; Iglesias, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB